There is a current lack of effective mucosal vaccines against major gastroenteric pathogens and particularly against Helicobacter pylori, which causes a chronic infection that can lead to peptic ulcers and gastric cancer in a subpopulation of infected individuals. Mucosal CD4 + T-cell responses have been shown to be essential for vaccine-induced protection against H. pylori infection. The current study addresses the influence of the adjuvant and site of mucosal immunization on early CD4 + T-cell priming to H. pylori antigens. The vaccine formulation consisted of H. pylori lysate antigens and mucosal adjuvants, cholera toxin (CT) or a detoxified double-mutant heat-labile enterotoxin from Escherichia coli (dmLT), which were administered by either the sublingual or intragastric route. We report that in vitro, adjuvants CT and dmLT induce up-regulation of proinflammatory gene expression in purified dendritic cells and enhance the H. pylori-specific CD4 + T-cell response including interleukin-17A (IL- 
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There is a current lack of effective mucosal vaccines against major gastroenteric pathogens and particularly against Helicobacter pylori, which causes a chronic infection that can lead to peptic ulcers and gastric cancer in a subpopulation of infected individuals. Mucosal CD4 + T-cell responses have been shown to be essential for vaccine-induced protection against H. pylori infection. The current study addresses the influence of the adjuvant and site of mucosal immunization on early CD4 + T-cell priming to H. pylori antigens. The vaccine formulation consisted of H. pylori lysate antigens and mucosal adjuvants, cholera toxin (CT) or a detoxified double-mutant heat-labile enterotoxin from Escherichia coli (dmLT), which were administered by either the sublingual or intragastric route. We report that in vitro, adjuvants CT and dmLT induce up-regulation of proinflammatory gene expression in purified dendritic cells and enhance the H. pylori-specific CD4 + T-cell response including interleukin-17A (IL-17A), interferon-c (IFN-c) and tumour necrosis factor-a (TNF-a) secretion. In vivo, sublingual immunization led to an increased frequency of IL-17A + , IFN-c + and TNF-a + secreting CD4 + T cells in the cervical lymph nodes compared with in the mesenteric lymph nodes after intragastric immunization. Subsequently, IL-17A + cells were visualized in the stomach of sublingually immunized and challenged mice. In summary, our results
Introduction
Helicobacter pylori infection in the stomach is a common cause of peptic ulcer disease and is a strong risk factor for the development of gastric adenocarcinoma. Infection is characterized by gastritis that remains chronic for decades, with an influx of immune cells such as dendritic cells (DCs), M1 and M2 macrophages, eosinophils, neutrophils and lymphocytes. 1 The recruited immune cells secrete a range of pro-inflammatory cytokines such as interleukin-12p40 (IL-12p40), IL-1b, tumour necrosis factor-a (TNF-a), interferon-c (IFN-c) and IL-17A. Studies in the H. pylori mouse model have shown that mucosal vaccination with H. pylori antigens and a mucosal adjuvant results in a 10-to 100-fold reduction in bacterial load compared with unvaccinated mice. 2 To date the essential requirements for successful vaccination against H. pylori infection have been reported to be CD4 + T cells, functional leptin receptor 3 and IL-17A, [4] [5] [6] but not antibodies or neutrophils. 7, 8 Clearly, we need to improve our understanding of how CD4 + T cells are induced at the site of immunization, and how the bacteria in the stomach can be safely eliminated in symptomatic individuals. However, we still lack studies addressing the importance of the adjuvant and site of mucosal immunization on the activation of CD4 + T cells and cytokine production.
The intragastric and sublingual (under the tongue) routes of mucosal immunization are both attractive routes for vaccination against H. pylori infection because of their ability to induce protection and mucosal cytokine responses. 4, 9, 10 In addition, the advantage of the mucosal route of vaccination is that it is needle-free, reducing infection risks and costs of delivery. The sublingual route of immunization has recently received attention as an alternative to the intranasal route for inducing mucosal immune responses. 11 The cervical lymph nodes (CLN) are the draining lymph nodes for the sublingual route of immunization. In mice, the sublingual mucosa is composed of a dense network of dendritic-like cells of which the majority are thought to be MHC-II + mature DCs. 12 Local administration of the model antigen ovalbumin together with the adjuvant cholera toxin (CT) has been shown to recruit MHC-II + DCs to the sublingual mucosa as well as effectively prime naive CD4 + T cells in the CLN promoting mucosal and systemic mixed T helper type 1 (Th1) and Th2 responses. 12, 13 In addition, recent studies have shown that as a site of vaccination, the sublingual mucosa can induce T effector cells that then can migrate to other mucosal sites such as the genital tract, lungs, small intestine and stomach to perform their effector functions. 11, 14, 15 The draining lymph nodes for the gastrointestinal tract are mesenteric lymph nodes (MLN). Specific subsets of DCs in the Peyer's patches can take up antigen and migrate to the MLN for presentation and activation of CD4 + T cells. 16 After activation and differentiation, the CD4 + cells guided by expression of adhesion molecules and chemokine receptors can migrate back to the stomach, small or large intestine lamina propria and perform effector functions. The gastrointestinal tract is also the main site for induction of tolerance to food antigens and so a combination of antigen and a mucosal adjuvant is essential for overcoming the intrinsically suppressive environment and inducing protective CD4 + T-cell immune responses against H. pylori infection. 10 Indeed, we and others have shown in the H. pylori mouse model that neither antigens nor adjuvants alone induce any immune responses to H. pylori antigens, or protection against challenge with live bacteria. 2 The mucosal adjuvant CT is widely used in animal models as a reference standard, for its ability to induce strong mucosal responses that are protective against H. pylori infection specifically due to the expansion of Th1 and Th17 cells to co-administered antigens. 4, 5, 7 Intense research efforts in the past few years have focused on developing detoxified enterotoxins and evaluating their potential as mucosal adjuvants. 17 These include among others, the double-mutant heat-labile toxin (dmLT) from enterotoxigenic Escherichia coli and the multiple-mutant cholera toxin. 18, 19 Indeed, dmLT can induce strong mucosal immune responses to H. pylori antigens and protection against infection in the mouse model, and is safe for use in humans -as seen in a Phase I trial for an oral vaccine. [20] [21] [22] Our previous studies in the H. pylori immunization model have shown that the sublingual route of immunization is dose sparing for the vaccine antigen and adjuvant compared with immunization via the intragastric route. 4, 10, 20, 23, 24 We now report that, in vitro, when DCs isolated from the CLN or MLN are pulsed with H. pylori antigens and CT and dmLT adjuvants, they are able to effectively activate H. pylori-specific CD4 + T cells and induce their cytokine secretion. However, when studying mucosal priming in vivo the sublingual route of immunization had a tendency to induce a stronger cytokine response from CD4 + T cells in the CLN compared with the response seen in the MLN after intragastric immunization. Sublingually immunized mice challenged with live H. pylori also had a tendency for an increased staining for IL-17A + cells in the stomach compared with intragastrically immunized mice. Our studies indicate that the dosesparing effects of the sublingual route of immunization might be related to the induction of a stronger cytokine secretion and earlier kinetics of a CD4 + T-cell response compared with the response induced by the intragastric route. The results presented in this study have potential implications for the design of an H. pylori vaccine and choice of administration route for Phase I clinical trials.
Materials and methods

Mice
Six-to eight-week-old, specific-pathogen-free, female C57BL/6 mice and ovalbumin T-cell transgenic mice (OT-II) (from in-house breeding), which are homozygous for a transgene that encodes a T-cell receptor specific for chicken ovalbumin (amino acids 323-339), presented on the MHC class II molecule I-Ab were used. Age-matched, specific-pathogen-free wild-type female C57BL/6 mice were bought from Taconic (Ejby, Denmark). The mice were housed in microisolators at the Laboratory for Experimental Biomedicine during the time of the study. All experiments were approved by the ethics committee for animal experiments (Gothenburg, Sweden). ulcer was prepared as previously described. 10 The protein content of the lysate antigens was measured using the non-interfering protein assay kit (Calbiochem, San Diego, CA). The antigen preparation was aliquoted and stored at À70°until further use and not subjected to multiple freeze-thaw cycles. Aliquots of H. pylori lysate antigens were freeze-dried and reconstituted to a protein concentration of 20 mg/ml to reduce the volume used for the sublingual immunizations. The same dose of antigens was used for intragastric immunization as for sublingual immunizations and administered together with sodium bicarbonate buffer. Lyophilized CT from Vibrio cholera (Sigma Aldrich, St Louis, MO) was reconstituted in sterile distilled water to a concentration of 1 mg/ml (and stored in aliquots at À70°until further use). Lyophilized dmLT (R192G/L211A) from E. coli was prepared as described elsewhere, 25 was reconstituted in sterile distilled water to a concentration of 1 mg/ml and stored at 4°until further use.
H. pylori lysate antigens preparation and immunizations
Cultivation of H. pylori SS1 used for infection of sublingually immunized mice Helicobacter pylori Sydney strain 1 (SS1) was cultured on Colombia iso-agar plates for 2-3 days and then cultured overnight in Brucella broth (Becton, Dickinson and Company (BD), Sparks, MD) in a microaerophilic environment as described previously. 10 The optical density was adjusted to 1Á5 and viability of the bacteria was ensured by visualization under a microscope, and 300 ll was administered intragastrically to each mouse. Each dose corresponded to approximately 3 9 10 8 viable bacteria.
Cultivation of Flt3 ligand tumour cells used for injection and expansion of CD11c
+ DCs in vivo Flt3L-secreting B16-F10 melanoma was obtained from Nicolas Mach 26 and was stored in liquid nitrogen, thawed and cultured for 2-3 days in a 25-mm 2 flask in Iscove's modified Dulbecco's medium (Biochrome, Berlin, Germany) supplemented with 10% heat-inactivated fetal calf serum (Sigma), 50 lM 2-mercaptoethanol (Sigma), 1 mM L-glutamine (Biochrome) and 50 lg/ml gentamicin (Sigma) (Iscove's complete medium) at 37°and in 5% CO 2 atmosphere. At confluence, cells were collected, washed and resuspended in fresh Iscove's complete medium and cultivated further for 2-3 days in a 75-mm 2 cell culture flask. On the day of injection, the cells were collected, washed and resuspended in fresh Iscove's modified Dulbecco's medium without supplements and counted. Each mouse was administered a total of 1 9 10 6 cells injected subcutaneously. The mice were palpated to follow tumour growth and euthanized when the tumour size had reached 100 mm 3 .
Dendritic cell culture, RNA extraction and cDNA preparation for PCR array Dendritic cell culture. Single-cell suspensions were prepared from the spleens of Flt3L-treated mice. CD11c + cells were enriched from total spleen cells by CD11c + positive selection using magnetically labelled MACS beads (Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of the CD11c DCs in repeated isolations was typically > 90%. CD11c + DCs cultured for RNA extraction were seeded (4 9 10 6 DCs per well) in the presence or absence of 1 lg/ml CT or dmLT and cultured for 4 hr in Iscove's complete medium at 37°in a 5% CO 2 atmosphere. Cells were collected after incubation, thoroughly washed to remove all culture medium and additives and resuspended in 350 ll RLT lysis Buffer (Qiagen, Duesseldorf, Germany) for downstream RT-PCR application. The samples were stored at À70°.
RNA extraction and cDNA preparation. RNA was extracted by using a shredder column and RNeasy mini kit (Qiagen) and purity and concentration were measured using the fluorospectrophotometer NanoDrop ND-1000 (ThermoFisher Scientific, Wilmington, DE). RNA (2 lg) was reverse transcribed into cDNA using the Quantitect kit (Qiagen).
RT-PCR array. Complementary DNA (2 lg) was run in 96-well array plates (Mouse dendritic and antigen-presenting cell array, SA Biosciences/Qiagen) according to the manufacturer's instructions using the 7500 RT-PCR Applied Biosystems system and 29 Power SYBR green master mix (Applied Biosystems, Foster City, CA). An average of the housekeeping genes b-actin, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), b2-microglobulin, b-glucuronidase and heat-shock protein 90ab1 was used as control. The difference between the sample gene and the average from the housekeeping genes (DCT value) was obtained and the relative fold change and expression were calculated by 2 DCT . The values for all samples were compared with non-stimulated cells and expressed as foldchange from non-stimulated samples. Validation was carried out with RNA (2 lg) that was first reverse transcribed into cDNA using the Quantitect kit (Qiagen). The samples were run in 96-well plates using the standard amplification settings for the 7500 RT-PCR system and 4 ll cDNA, 10 ll 29 Power SYBR green master mix (Applied Biosystems) and 1 ll of gene-specific oligonucleotide primers (Eurofins MWG Operon, Ebersberg, Germany). Each sample was run in duplicate and b-actin was used as a housekeeping gene control for the validation experiment. The difference between the sample gene and b-actin (DCT value) was obtained and the relative expression was calculated by 2 DCT . The values for all samples were calculated as fold change from non-stimulated cells. Preparation of OT-II T CD4 + T cells and co-culture with stimulated DCs. Spleen CD4 + T cells ovalbumin transgenic (OT-II) mice were prepared using a CD4 positive selection kit (Miltenyi). CD4
+ cells in repeated isolations were typically > 90%. Stimulated or unstimulated DCs were seeded (1 9 10 4 DCs per well) together with CD4 + OT-II spleen T cells (1 9 10 5 per well) in a sterile 96-well plate and left for 5 days in 37°in a 5% CO 2 atmosphere. Supernatants were collected and stored at À70°for subsequent cytokine analysis. To determine proliferation (radioactive thymidine incorporation assay), the cells were pulsed with 1 lCi of [ 3 H]thymidine (Amersham Bioscience, Buckinghamshire, UK) for the last 6-8 hr of culture. The cellular DNA was collected with a cell harvester (Skatron) on glass fibre filters (Perkin Elmer, Upplands Väsby, Sweden) and assayed for 3 H incorporation using a liquid scintillation counter (Beckman, LKB, Bromma, Sweden). Preparation of CD4 + T cells and co-culture with stimulated DCs. The MLN was isolated from mice sublingually immunized with H. pylori lysate antigens and 10 lg CT and infected with H. pylori SS1. The CD4 + T cells from the MLN were enriched by CD4 + positive selection using magnetically labelled MACS beads (Miltenyi). Stimulated or unstimulated DCs were seeded (1 9 10 4 DCs per well) together with CD4 + H. pylori-specific MLN T cells (1 9 10 5 per well) in a sterile 96-well plate and left for 5 days in 37°in a 5% CO 2 atmosphere. Supernatants were collected and stored at À70°for subsequent cytokine analysis. Proliferation was determined by the radioactive thymidine incorporation assay.
Cytokines analysed by Cytometric Bead Array Flex Set
Supernatant from the proliferation assay was analysed for cytokines IL-17A, IFN-c and TNF-a using Cytometric Bead Assay Flex Set beads according to the manufacturer's protocol (BD Biosciences, San Jose, CA).
Sublingual or intragastric immunization and treatment with FTY720
Mice were prophylactically immunized via the sublingual or intragastric route with 400 lg H. pylori lysate antigens and 10 lg of adjuvant CT or dmLT as previously described.
20 FTY720 (Cayman Chemicals, Ann Arbor, MI), a structural analogue of sphingosine and potent agonist of the sphingosine-1-phosphate receptors, was administered to prevent the egress of lymphocytes from the lymph nodes after immunization. FTY720 was diluted to 0Á5 mg/ml in physiological saline and each mouse was administered a dose 0Á025 mg intraperitoneally. The FTY720 treatment was started 1 day before immunization and continued for 6 days and the mice were euthanized on day 7 after immunization. To ensure that the FTY720 treatment was effective, blood was collected on day 3 and day 7 after immunization stained for lymphocytes CD3, CD4 and CD8 and analysed by flow cytometry.
Flow cytometric analysis
The MLN and CLN cells from mice immunized by the sublingual and intragastric routes and treated with FTY720 were isolated and single cell suspensions were prepared. For cytokine staining, cells were stimulated with 20 ng/ml PMA (Sigma) and 1 lg/ml Ionomycin (Sigma) in Iscove's complete medium for 2 hr at 37°in a 5% CO 2 atmosphere. After 2 hr, 10 lg/ml Brefeldin A (Sigma) in Iscove's complete medium was added to the cells and left for a further 2 hr at 37°in a 5% CO 2 atmosphere. Surface and intracellular staining was carried out using anti-mouse CD3-Peridinin chlorophyll protein, CD4-Alexa Fluor 700, TNF-a-Phycoerythrin-Cy7 and IFN-c-allophycocyanin (all BD Biosciences) and IL-17A-FITC (eBioscience, San Diego, CA) and a Live/Dead Fixable Aqua Dead Cell Stain Kit was used to stain dead cells before fixation (Life Technologies, Carlsbad, CA). The stained cells were acquired using the LSR-II Flow Cytometer (BD) and analysed using the FLOWJO software version 7.6.5 (FlowJo, Ashland, OR).
Immunohistochemistry staining for IL-17A
A vertical strip from the entire stomach taken from sublingually immunized mice 3 weeks after infection was frozen in embedding medium OCT (Histolab, Gothenburg, Sweden) and the frozen blocks were stored at À70°until further use. Sections (7 lm) were cut and allowed to dry followed by fixation with 100% ice-cold acetone. Sections were permeabilized with 0Á5% Triton X-100 (Sigma) and then blocked with 10% goat serum (Sigma) and Fc-c receptor block. The blocking solution was blotted out and primary antibody rat anti-mouse IL-17A-FITC (eBioscience) or rat isotype-FITC control (eBioscience) was added in 0Á1% Triton X-100 and incubated at room temperature. Sections were washed in PBS and mounted using a mounting medium prolong â gold antifade (Molecular Probes, Eugene, OR) containing DAPI. Interleukin-17A staining in the lamina propria was then visualized using a fluorescence microscope (Zeiss Axioplex 2). Images were analysed using the BIOPIX software (Biopix, G€ oteborg, Sweden) for histological quantification of IL-17A + cells and compared with the total area of lamina propria in each stomach section.
Statistical analysis
Analysis of variance (ANOVA) with Sidak's post-test was used to compare multiple groups of mice using GRAPHPAD PRISM software version 6.0 (GraphPad Software Inc., San Diego, CA). For all tests, a P-value of < 0Á05 was considered to be statistically significant.
Results
Adjuvants CT and dmLT induce comparable in vitro gene expression of pro-inflammatory molecules in DCs
Our aim was to study the mechanisms of mucosal adjuvant function and particularly their influence on DCs as they are among the first cells to come in contact with the antigen and adjuvant at the site of immunization and also to directly influence T-cell priming. CD11c + DCs were isolated using MACS beads from the spleen of mice injected previously with Flt3L-secreting melanoma cells and stimulated in vitro with 1 lg/ml each of CT or dmLT. The DCs were collected after 4 hr of stimulation with the adjuvants and gene expression in the cells was evaluated using the Qiagen mouse dendritic and antigenpresenting cell PCR array. Compared with unstimulated DCs, stimulation of DCs in the presence of 1 µg/ml of CT or dmLT up-regulated activation markers such as CD80 and CD86 to a similar extent (2-and 1Á5-fold, respectively) ( Table. 1 ). In addition, CXCL2 and thrombospondin-1 was highly up-regulated after stimulation with CT (11-fold and 67-fold, respectively) and to a lesser extent after stimulation with dmLT (2-fold and 29-fold, respectively) ( Table 1) . Cholera toxin also induced higher up-regulation of IL-6 compared with dmLT, whereas dmLT stimulated elevated up-regulation of IFN-c compared with CT (Table 1) . Several genes were also downregulated compared with unstimulated cells, for example chemokine receptors, toll-like receptors and CD4 ( Table 2) . Validation of the PCR array results was performed using in-house primers for CXCL2, IL-6 and IFN-c that confirmed our results of the PCR array (data not shown). Hence, CT and dmLT induced elevated gene expression of activation markers, chemokines and cytokines in DCs, which might explain the potent adjuvant activity in vivo.
In vitro activation and proliferation of CD4 + T cells from CLN and MLN is dependent on the dose of adjuvant and type of antigen
We next wanted to address the induction and priming of CD4 + T-cell responses, by in vitro activated DCs from the CLN and MLN in the presence or absence of adjuvants CT and dmLT. First, the optimal dose of adjuvant required to stimulate CD4 + T-cell responses was evaluated by using ovalbumin transgenic CD4 + T cells (OT-II) and DCs isolated from CLN and MLN of previously Flt3L melanoma-injected mice, pulsed in vitro with 10 À1 , 10 À3 ,
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À5 and 10 À7 lg/ml of CT or dmLT together with ovalbumin for 4 hr. The DCs were then thoroughly washed, counted and co-cultured with purified CD4 + T cells isolated from the spleen of OT-II mice and proliferative responses were measured. The results showed that a concentration of 10 À1 lg/ml CT or dmLT was significantly anti-proliferative to the CD4 + T cells in the presence of CT but not dmLT. The presence of antigen and 10 À3 , 10 À5 or 10 À7 lg/ml of CT or dmLT induced significantly higher proliferative responses by the CD4 + T cells compared with the response to ovalbumin alone without adjuvant (Fig. 1a) . The CD4 + T-cell proliferation induced by DCs isolated from CLN or MLN were comparable (Fig. 1a) .
Secretion of IL-17A, IFN-c and TNF-a cytokines by the proliferated CD4 + T cells was evaluated. As the strongest proliferative response by the CD4 + T cells was seen in the presence of DCs pulsed with 10 À3 lg/ml of adjuvant and ovalbumin, the cytokine level in the supernatant from this particular culture was analysed. In the DCs isolated from the CLN but not MLN, enhanced secretion of IL-17A and IFN-c by the CD4 + T cells was seen in the presence of CT and ovalbumin. The IL-17A levels were low in the culture supernatants despite CT and dmLT inducing strong proliferative responses (Fig. 1b-d) .
We next evaluated DC priming of CD4 + T-cell responses to H. pylori lysate antigens. The DCs isolated from CLN and MLN of Flt3L melanoma-implanted mice were pulsed for 4 hr in vitro with 10 À3 lg/ml of CT or dmLT together with 20 µg/ml H. pylori lysate antigens. The DCs were then washed thoroughly and mixed with responder CD4 + T cells isolated from the MLN of H. pylori-infected sublingually immunized mice. The results showed that DCs pulsed with CT induced a significantly stronger CD4 + T-cell proliferative response than DCs pulsed with dmLT, irrespective of whether they were isolated from CLN or MLN (Fig. 2a) . Cytokine analysis was carried out in the supernatants, which showed not only high levels of IL-17A but also of IFN-c and TNF-a, particularly in cultures containing DCs isolated from the MLN (Fig. 2b-d) .
In summary in the presence of antigen and 10 À3 lg/ml of CT or dmLT in culture, enhanced proliferation of CD4 + T cells could be observed with high IL-17A cytokine secretion, particularly in response to H. pylori antigen.
Enhanced in vivo cytokine responses in the CLN after sublingual immunization compared with MLN after intragastric immunization
Although our in vitro results gave us some indication of the effects of adjuvants on priming CD4 + T-cell responses, we were interested in relating it to in vivo CD4 + T-cell priming by H. pylori antigens in combination with adjuvants. FTY720 was administered intraperitoneally to prevent the exit of lymphocytes from the lymph nodes, so that the immune responses could be studied in isolation. Mice were immunized sublingually or intragastrically with H. pylori lysate antigens and CT or dmLT. The CLN and MLN were collected 7 days after immunization and single-cell suspensions were prepared. After a brief stimulation with PMA and ionomycin, flow cytometric staining and analysis were performed for cell surface markers and intracellular cytokines IL-17A, IFN-c and TNF-a. Live cells were gated for CD3 + and CD4 + T cells and the cytokine secretion was analysed in the gated population in the different groups of mice. Sublingual immunization with CT induced a significant increase (P < 0Á05) in the frequency and number of T cells secreting IL-17A and TNF-a and double-positive IL-17A + IFNc + and TNF-a + IL-17A + cells in CLN compared with cells isolated from the CLN of unimmunized naive mice (Fig. 3a-g and see Supplementary material, Fig. S1a-f) . Remarkably, sublingual immunization with dmLT also induced a significant increase (P < 0Á05) in the frequency and number of CD4 + T cells secreting IL-17A, TNF-a and double-positive IL-17A + IFN-c + and TNF-a + IL-17A + cells in CLN compared with cells isolated from the CLN of unimmunized naive mice (Fig. 3a-g and see Supplementary material, Fig. S1a-g ). Finally, intragastric The difference between housekeeping genes and the target gene (ΔCT) was determined, and the relative expression was calculated using the formula 2 ΔCT . Values are then expressed as fold change compared with dendritic cells stimulated without adjuvant. In the CLN of sublingually immunized mice with H. pylori lysate antigens and CT a significant (P < 0Á05) increase in the total number of CD3 + CD4 + T cells was also observed compared with unimmunized naive mice (see Supplementary material, Fig. S1g) . Finally, Foxp3 expression in total cells isolated from MLN and CLN of immunized mice was determined and we found an upregulation of Foxp3 in the total MLN but not CLN cells from immunized compared with unimmunized mice (data not shown). In summary, our results showed that vaccination with H. pylori antigens and either CT or dmLT induced a pro-inflammatory cytokine secretion by CD4 + T cells in the CLN after sublingual immunization.
Sublingual immunization with H. pylori lysate antigens induces an IL-17A response in the stomach
Our in vivo results gave us insight into the cytokine response by CD4 + T cells after immunization in the draining lymph nodes and noticeably after sublingual immunization the IL-17A response was elevated in the CLN. Hence, we wanted to investigate whether the primed cells migrate to the stomach of mice after infection. Mice were immunized either sublingually or intragastrically, with H. pylori lysate antigens and CT or dmLT and challenged 2 weeks after the last immunization + staining in all mice was mostly restricted to the lamina propria and so to be able to compare between groups of mice, only these cells were counted and not the few cells residing at the epithelium or submucosa of the stomach (Fig. 4a) . The frequency of IL-17A + cells in the stomach was significantly higher (P < 0Á05) in sublingually immunized compared with intragastrically immunized mice when using either CT or dmLT as adjuvant (Fig. 4b) . This suggests that the IL-17A + cells can be detected in the stomach particularly in sublingually immunized mice.
Discussion
The aim of the current study was to elucidate the mechanisms of T-cell priming and cytokine induction in the draining lymph nodes after mucosal immunization; CLN for the sublingual route and MLN for the intragastric route, and compare the effect of using CT or dmLT as adjuvants together with an H. pylori vaccine. We first evaluated the direct effect of adjuvant CT or dmLT on DC activation and T-cell priming by assessing gene expression in DCs in response to the adjuvants. Both adjuvants induced high gene expression of pro-inflammatory molecules compared with unstimulated DCs, although CT induced higher gene expression overall than dmLT. One of the genes that was highly up-regulated in the DCs pulsed with CT and to a lesser extent dmLT was that for thrombospondin-1. Thrombospondin-1 is a potent activator of neutrophils and plays an important role in inflammatory responses, angiogenesis, platelet aggregation, vasodilatation, leucocyte migration and chemotaxis. 27 Preliminary results in our laboratory have shown an up-regulation in the 28, 29 Co-culture of DCs pulsed with antigen and adjuvant with CD4 + T cells showed clearly that both CT as previously known, 30 and dmLT were anti-proliferative to T cells at high concentrations and careful titration of the adjuvant is necessary to observe the potentiating effects of the adjuvants on the CD4 + T-cell response. The in vitro anti-proliferative effects of CT have been previously shown to the result of the induction of second messenger cAMP in the cells. 31 However, it was noteworthy that dmLT, which is a detoxified molecule, was anti-proliferative to CD4
+ T cells at the highest concentration, indicating that the adjuvant effect and activation of DCs might be related to the low amounts of cAMP each dot represents an individual mouse. Data pool 2 independent experiments with two to five mice/group. White circles represent infected unimmunized controls, black circles represent mice immunized with lysate and CT and grey circles represent mice immunized with lysate and dmLT. *P < 0Á05. Each symbol represents an individual mouse; data pool two independent experiments with two or three mice/group. White circles represent naive mice, black circles represent mice immunized with lysate and CT and grey circles represent mice immunized with lysate and dmLT. *P < 0Á05, **P < 0Á01 and ***P < 0Á001. + T cells failed to respond after co-culture with DCs isolated in vivo from the immunized mice, possibly due to the low frequency of DCs that had specifically taken up ovalbumin antigen (data not shown).
By analysing the CD4 + T cells in vivo in the CLN and MLN after sublingual or intragastric immunization, respectively, we could further show that cytokine responses are particularly increased in the CLN after sublingual immunization. Interestingly, a selective up-regulation of the frequency of IL-17A-and TNF-a-secreting CD4 + T cells was seen. We have previously shown that the sublingual route of immunization induces a strong IL-17A response in the stomach when using H. pylori lysate antigens and either CT or dmLT as adjuvants. 20 We can now show that the induction of the IL-17A secretion by CD4 + T cells takes place in the CLN after sublingual immunization. In general, H. pylori lysate antigens and adjuvant CT induced a stronger cytokine secretion from CD4 + T cells compared with adjuvant dmLT in the CLN whereas very weak responses were detected in the MLN. Preliminary results in our laboratory have shown that, when the dose of antigens and adjuvant was increased for intragastric immunization, similar protection against H. pylori infection could be seen as for the lower dose used for sublingual immunization (F. Jeverstam, M. Blomquist, S. Karlsson, J. Tobias, J. Holmgren and S. Raghavan, unpublished) . The sublingual route of immunization can therefore be regarded as dose sparing in the H. pylori vaccination model.
Mice fed CT intragastrically have been shown to have MHC-II + DC numbers increased in the follicle-associated epithelium of the Peyer's patches also within 1 hr and to decline between 8 and 12 hr, promoting the migration of DCs from the subepithelial dome underlying the follicleassociated epithelium to the T-cell and B-cell areas. 32 Hence, during immunization, in addition to activating DCs, CT might increase the possibility for DCs to capture the incoming antigens due their localization and subsequent priming of the CD4 + T-cell response. 33 However, we observed that the cytokine response (both IL-17A and IFN-c) by the CD4 + T cells in MLN after intragastric immunization was relatively low suggesting that that either the Peyer's patches or possibly the paragastric lymph nodes are the priming site for vaccine-induced Tcell responses. CD4 + T cells isolated from the paragastric lymph nodes of BALB/c mice vaccinated with a recombinant attenuated Salmonella Typhimurium-based vaccine can proliferate in response to H. pylori antigens in vitro.
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A strong cytokine response was found in the CLN after sublingual immunization in this study, which could not be detected in the MLN early after intragastric immunization, suggesting that cytokine secretion by CD4 + T cells in the MLN is either weak or takes place at a different location or time-point.
To study the migration of IL-17A-secreting cells to the stomach, we analysed the staining pattern of the IL-17A in mice immunized by the sublingual or intragastric route after challenge with H. pylori. In sublingually immunized mice there was an increase in the frequency of IL-17A + cells in the stomach lamina propria after infection. Given the well-known importance of CD4 + T cells in vaccine induced protection against H. pylori, we expect that the IL-17A-secreting cells are Th17 cells; however, this is a subject of ongoing studies. Notably, the IL-17A staining in the sublingually immunized mice was in close proximity to the epithelial cells, indicating that IL-17A might have direct effects on the epithelial cells in inducing, for example, chemokines and anti-microbial peptide secretion. 34 This can be supported by a recent study showing that the combination of recombinant IL-17A and IL-22 can induce antimicrobial peptide and defensin production in human gastrointestinal epithelial cells as well as in mouse primary gastric epithelial cells. 35 In addition, the same study showed that the combination of these two cytokines conferred increased killing of H. pylori in vitro in human cell lines.
In summary, our data confirm previous results that CT and dmLT have similar adjuvant potential and support them with the findings that they have similar effects on the gene expression in DCs, as well as the activation and priming of CD4 + T cells. However, at the same dose, immunization with either CT or dmLT induces a stronger cytokine response in the draining lymph node CLN after sublingual immunization compared with in the MLN after intragastric immunization. These studies provide a basis for making an informed choice when designing clinical trials of H. pylori vaccines.
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